Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000317·JANUS HENDERSON GROUP PLC
Schedule 13G ownership disclosure
Monopar Therapeutics Inc
Common Stock · CUSIP: 61023L207
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 1,287,368 · Class: 19.5%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 1,105,471 · Class: 16.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000317
- Form type
- SCHEDULE 13G/A
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership